2149 |
MSCT Is Mandatory Before and Useful After TAVI |
Bernard R. Chevalier |
May. 09. 14 |
2148 |
Echocardiographic Evaluation of AV Hemodynamics and Morphology |
Jong-Min Song |
May. 09. 14 |
2147 |
Beyond D2B Time: What Is The Next Solutions? |
Naoto Inoue |
May. 09. 14 |
2146 |
Speed to Treatment: Faster D2B Time, but Not Fewer Death |
Mun Kyung Hong |
May. 09. 14 |
2145 |
TASTE Trial: No Benefits, Time to Rethink? |
Bernard R. Chevalier |
May. 09. 14 |
2144 |
Guideline Today: Some Benefits, Optional Choice |
Cindy L. Grines |
May. 09. 14 |
2143 |
PRAMI Trial: A Big Challenge, but Execution Doubtful! |
Issam D. Moussa |
May. 09. 14 |
2142 |
Guideline Today: Focus on the Culprit! |
David R. Holmes |
May. 09. 14 |
2141 |
Duration of DAPT: Is 3 Months Enough in the Era of New DES? |
Sorin Brener |
May. 09. 14 |
2140 |
PARIS Study: Discontinuation, Interruption & Disruption in a Real-World Patients |
Mun Kyung Hong |
May. 09. 14 |